New anti-tuberculosis drugs and regimens: 2015 update
Over 480 000 cases of multidrug-resistant (MDR) tuberculosis (TB) occur every year globally, 9% of them being affected by extensively drug-resistant (XDR) strains of Mycobacterium tuberculosis. The treatment of MDR/XDR-TB is unfortunately long, toxic and expensive, and the success rate largely unsat...
| Main Authors: | , , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
European Respiratory Society
2015
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5005131/ |